Drug-labels.com

Act Pemetrexed: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
100 mg, 500 mg, 1000 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Act Pemetrexed

ABOUT THIS MEDICATION

What the medication is used for:

ACT Pemetrexed is used in the treatment of the following types of cancers:

  • Malignant pleural mesothelioma (cancer of the lining of the chest cavity) in combination with cisplatin (another anti- cancer drug).
  • Nonsquamous locally advanced or metastatic non-small cell lung cancer as:

    o Initial treatment in combination with cisplatin.

    o Maintenance treatment given alone immediately after four cycles of platinum-based first-line chemotherapy.

    o Second line treatment given alone after prior chemotherapy.

What it does:

ACT Pemetrexed is an antifolate anticancer agent that works by disrupting the metabolic processes that are essential for cell replication. It helps to stop the cancer cells from multiplying.

When it should not be used:

Do not take ACT Pemetrexed if you:

  • are allergic to pemetrexed disodium or any of the

    ingredients in ACT Pemetrexed.

  • have received or are going to receive the Yellow Fever

    vaccine.

What the medicinal ingredient is:

ACT Pemetrexed contains the active ingredient called pemetrexed disodium.

What the important nonmedicinal ingredients are:

ACT Pemetrexed contains mannitol. Hydrochloric acid and/or sodium hydroxide, may have been added to adjust pH.

What dosage forms it comes in:

ACT Pemetrexed is supplied as sterile freeze-dried powder for intravenous infusion and is available in single-dose vials. Each vial contains either 100 mg, 500 mg or 1000 mg pemetrexed as pemetrexed disodium

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

  • ACT Pemetrexed should be administered under the supervision of a qualified physician experienced in the use of anticancer agents.
  • Liver toxicity and rare cases of fatal liver failure have been reported in clinical trial patients treated with Pemetrexed Disodium alone or in combination with other anticancer drugs.

To lower your chances of side effects of ACT Pemetrexed, you must also take folic acid and vitamin B12 injections prior to and during your treatment with ACT Pemetrexed.

BEFORE you use ACT Pemetrexed talk to your doctor or pharmacist if:

  • you have a severe hypersensitivity reaction to ACT Pemetrexed or to any other ingredient used in the formulation.
  • you are pregnant or planning to get pregnant (ACT Pemetrexed may cause harm to an unborn child).

  • you plan to father a child. (ACT Pemetrexed may cause irreversible infertility).
  • you are breast feeding.
  • you are under 18 years old.
  • you have a kidney disease.
  • you have a liver disease.
  • you have a heart problem.
  • you have ever had radiation therapy.
  • you have recently received or are planning on receiving a vaccine against Yellow Fever or any live vaccines.

You should discuss effective birth control methods with your doctor. Male patients should not father a child during the treatment and up to 6 months after stopping the treatment.

INTERACTIONS WITH THIS MEDICATION

Tell your doctor or pharmacist if you are taking or have taken other medications, including prescription and nonprescription medicines, vitamins, and natural health products.

Drugs that may interact with ACT Pemetrexed include:

  • NSAIDs (nonsteroidal anti-inflammatory drugs, e.g. ibuprofen): you should stop taking them for at least 5 days before, the day of, and at least 2 days after ACT Pemetrexed treatment. If it is necessary to take NSAIDs inform your doctor and you will be monitored accordingly.

PROPER USE OF THIS MEDICATION

Usual dose:

ACT Pemetrexed is slowly infused (injected) into a vein. The injection or infusion will last about 10 minutes. You will usually receive ACT Pemetrexed once every 21 days (3 weeks).

You may receive ACT Pemetrexed alone or in combination with cisplatin, another anti-cancer agent. Your doctor will determine your treatment plan, be sure to ask your doctor or health care team if you have any questions.

If your doctor has prescribed cisplatin, it will be infused in your vein for about 2 hours starting about 30 minutes after your treatment with ACT Pemetrexed.

Pre-Medications

To lower your chances of experiencing harmful side effects, it is important for you to take the following medication and vitamins prior to and/or during your treatment with ACT Pemetrexed.

Corticosteroid

Your doctor will prescribe a medicine called a “corticosteroid” to take the day before, the day of, and the day after ACT Pemetrexed treatment. Corticosteroid medicines lower your chances for getting skin reactions with ACT Pemetrexed.

Folic Acid Tablets

You must start taking 350- 600 micrograms of folic acid every day for at least 5 days out of the 7 days before your first dose of ACT Pemetrexed. You must keep taking folic acid every day during the time you are getting treatment with ACT Pemetrexed and for 21 days after your last treatment.

You can get folic acid vitamins over-the-counter. Folic acid is also found in many multivitamin pills. Ask your doctor or pharmacist for help if you are not sure how to choose a folic acid product.

Vitamin B12 Injection

Your doctor will give you vitamin B12 injections while you are

getting treatment with ACT Pemetrexed. You will get your first vitamin B12 injection during the week before your first dose of ACT Pemetrexed, and then about every 9 weeks during treatment until 3 weeks after the last dose of ACT Pemetrexed.

Contact your doctor if you forget to take your pre-medications.

You will have regular blood tests before and during your

treatment with ACT Pemetrexed. Your doctor may adjust your dose of ACT Pemetrexed or delay treatment based on the results of your blood tests and on your general condition.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

Contact your physician immediately for further instructions.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Most patients taking ACT Pemetrexed will have side effects. Sometimes it is not possible to tell whether ACT Pemetrexed, another medicine, or the cancer itself is causing these side effects. Call your doctor right away if you have a fever, chills, diarrhea, or mouth sores. These symptoms could mean you have an infection.

The most common side effects of Pemetrexed Disodium when taken alone or with cisplatin are:

  • Stomach upset, including nausea, vomiting, diarrhea, and constipation.
  • Low blood cell counts

    o Low red blood cells may make you feel tired, get tired easily, appear pale, and become short of breath.

    o Low white blood cells may give you a greater chance for infection. If you have a fever (temperature above 38°C) or other signs of infection, call your doctor right away.

    o Low platelets give you a greater chance for bleeding. Your doctor will do blood tests to check your blood counts before and during treatment with ACT Pemetrexed.

  • Tiredness. You may feel tired or weak for a few days after your ACT Pemetrexed treatments. If you have severe weakness or tiredness, call your doctor.
  • Mouth, throat, or lip sores (stomatitis, pharyngitis). You may get redness or sores in your mouth, throat, or on your lips. These symptoms may happen a few days after ACT Pemetrexed treatment. Talk with your doctor about proper mouth and throat care.
  • Loss of appetite. You may lose your appetite and lose weight during your treatment.
  • Kidney. Your kidney function may be decreased, sometimes seriously, which may make you feel unwell. Your doctor may do blood tests to monitor your kidney function.
  • Rash. You may get a rash or itching during treatment. These usually appear between treatments with ACT Pemetrexed and usually go away before the next treatment. Sometimes you may get severe skin reactions. Call your doctor if you get a severe rash or itching..
  • Fever.

Effects on heart and brain have been reported uncommonly in clinical studies. Severe effects on stomach and intestine including bleeding has been uncommonly reported in clinical studies. Sometimes the effects on intestine are worse after radiation. In clinical studies, severe effects on lung and breathing have been reported. Blood flow disturbance leading to tissue damage has been reported.

Rare cases of unusual swelling in the legs or the face (edema)

have been reported.

A small number of patients have reported changes in mood/ depression.

Be sure to tell your doctor if your breathing gets worse while you are on ACT Pemetrexed.

Talk with your doctor, nurse, or pharmacist about any side effect that bothers you or that doesn't go away. It is important that you continue to take your folic acid and vitamin B12 supplements even if you experience serious side effects.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency medical attention
Only if severeIn all cases
Common

Allergic

reaction

✓
Bleeding✓

Breathing

(Any change)

✓

Chest pain

(new or

worsening)

✓
Diarrhea✓
Fever✓

Mouth, throat

or lip sores

✓
Nausea✓
Skin rash✓

Swallowing

difficulty

✓
Tiredness✓
Vomiting✓

*Continue taking your folic acid and vitamin B12 injections even if you have serious side effects. Common=1% to <10%

This is not a complete list of side effects. For any unexpected effects while taking ACT Pemetrexed, contact your doctor or pharmacist.

HOW TO STORE IT

ACT Pemetrexed (pemetrexed disodium) should be stored at room temperature 15°C-30°C. Reconstituted and infusion solutions can be stored at refrigerated conditions (2°C-8°C) for up to 24 hours.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

--------------------------------------------------------------------------

  • $ Report online at www.healthcanada.gc.ca/medeffect
  • $ Call toll-free at 1-866-234-2345
  • $ Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, Ontario

      K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Actavis Pharma Company at:

1-866-254-6111

Last prepared: July 22, 2014.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02428768

Revision date stated in the text: July 22, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Act Pemetrexed

Rx or OTC
Prescription (Rx)?
DIN 02428768, 02428776, 02428784
Schedule(s) PRESCRIPTION
Active ingredient(s) Pemetrexed (pemetrexed disodium)
Dosage form(s) Powder For Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01B Antimetabolites
        1. L01BA Folic acid analogs, antimetabolites
          1. L01BA04 Pemetrexed
Company ACTAVIS PHARMA COMPANY
Current status Cancelled Pre Market
Current status date July 24, 2018
Strengths and forms
DIN Strength Dosage form(s) Current status
02428768 100 MG Powder For Solution Cancelled Pre Market July 24, 2018
02428776 500 MG Powder For Solution Cancelled Pre Market July 24, 2018
02428784 1000 MG Powder For Solution Cancelled Pre Market July 24, 2018

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.